Weatherly Asset Management L. P. Abb Vie Inc. Transaction History

Weatherly Asset Management L. P.

$1.2 Billion
Q3 2025

A detailed history of Weatherly Asset Management L. P. transactions in Abb Vie Inc. stock. As of the latest transaction made, Weatherly Asset Management L. P. holds 10,003 shares of ABBV stock, worth $2.34 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

10,003

Previous 9,853 1.52%

Holding current value

$2.34 Million

Previous $1.83 Million 26.7%

% of portfolio

0.19%

Previous 0.16%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 16, 2025	BUY	$184.85 - $231.54 $27,727 - $34,731	150 Added 1.52%	10,003 $2.32 Million
Q2 2025 Jul 11, 2025	SELL	$170.16 - $206.27 $510 - $618	-3 Reduced 0.03%	9,853 $1.83 Million
Q1 2025 May 01, 2025	SELL	$169.2 - $216.66 $10,490 - $13,432	-62 Reduced 0.63%	9,856 $2.07 Million
Q4 2024 Jan 29, 2025	SELL	$164.99 - $203.87 $15,179 - $18,756	-92 Reduced 0.92%	9,918 $1.76 Million
Q3 2024 Oct 28, 2024	BUY	$163.84 - $199.33 $188,743 - $229,628	1,152 Added 13.01%	10,010 $1.98 Million
Q2 2024 Jul 31, 2024	SELL	$154.79 - $180.76 $87,765 - $102,490	-567 Reduced 6.02%	8,858 $1.52 Million
Q4 2023 Feb 01, 2024	SELL	$137.6 - $154.97 $12,796 - $14,412	-93 Reduced 0.98%	9,425 $1.46 Million
Q2 2023 Jul 21, 2023	BUY	$132.51 - $164.9 $34,982 - $43,533	264 Added 2.85%	9,518 $1.28 Million
Q4 2022 Jan 10, 2023	BUY	$138.31 - $165.87 $1,383 - $1,658	10 Added 0.11%	9,254 $0
Q3 2022 Oct 17, 2022	SELL	$134.21 - $153.93 $10,334 - $11,852	-77 Reduced 0.83%	9,244 $1.24 Million
Q2 2022 Jul 18, 2022	SELL	$137.62 - $174.96 $27,524 - $34,992	-200 Reduced 2.1%	9,321 $1.43 Million
Q1 2022 May 06, 2022	BUY	$131.98 - $163.75 $11,086 - $13,755	84 Added 0.89%	9,521 $1.54 Million
Q2 2021 Aug 12, 2021	SELL	$105.21 - $117.21 $1,578 - $1,758	-15 Reduced 0.16%	9,437 $1.06 Million
Q3 2020 Oct 30, 2020	SELL	$85.91 - $100.83 $2,147 - $2,520	-25 Reduced 0.26%	9,452 $828,000
Q2 2020 Jul 29, 2020	BUY	$73.37 - $98.18 $104,185 - $139,415	1,420 Added 17.62%	9,477 $930,000
Q1 2020 May 01, 2020	SELL	$64.5 - $97.79 $838 - $1,271	-13 Reduced 0.16%	8,057 $614,000
Q4 2019 Jan 23, 2020	SELL	$72.13 - $90.25 $5,554 - $6,949	-77 Reduced 0.95%	8,070 $715,000
Q3 2019 Nov 07, 2019	SELL	$62.98 - $75.72 $10,706 - $12,872	-170 Reduced 2.04%	8,147 $617,000
Q2 2019 Jul 31, 2019	BUY	$65.7 - $83.98 $9,920 - $12,680	151 Added 1.85%	8,317 $605,000
Q1 2019 May 01, 2019	SELL	$77.14 - $90.79 $37,490 - $44,123	-486 Reduced 5.62%	8,166 $658,000
Q4 2018 Feb 12, 2019	SELL	$77.85 - $96.01 $12,066 - $14,881	-155 Reduced 1.76%	8,652 $798,000
Q3 2018 Nov 08, 2018	SELL	$88.91 - $98.84 $31,118 - $34,594	-350 Reduced 3.82%	8,807 $833,000
Q1 2018 May 07, 2018	SELL	$92.01 - $123.21 $213,187 - $285,477	-2,317 Reduced 20.19%	9,157 $867,000
Q4 2017 Jan 31, 2018	SELL	$89.56 - $98.21 $4,657 - $5,106	-52 Reduced 0.45%	11,474 $1.11 Million
Q3 2017 Oct 20, 2017	BUY	$69.85 - $89.22 $805,091 - $1.03 Million	11,526	11,526 $1.02 Million

Others Institutions Holding ABBV

# of Institutions

4,481

Shares Held

1.28B

Call Options Held

17.1M

Put Options Held

15.4M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $414B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Weatherly Asset Management L. P., based on Form 13F filings with the SEC.

News

Stay updated on Weatherly Asset Management L. P. with notifications on news.

Account

Weatherly Asset Management L. P. Abb Vie Inc. Transaction History